Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-034814

Director bought 935 shares at an average $4.83 ($4,513)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2025-06-02 Purchase 10b5-1 +45 $5.20 $234 285,743 D
Krogulski Kenneth Director 2025-06-03 Purchase 10b5-1 +45 $5.61 $252 285,788 D
Krogulski Kenneth Director 2025-06-04 Purchase 10b5-1 +45 $5.75 $259 285,833 D
Krogulski Kenneth Director 2025-06-05 Purchase 10b5-1 +45 $5.46 $246 285,878 D
Krogulski Kenneth Director 2025-06-06 Purchase 10b5-1 +45 $5.57 $251 285,923 D
Krogulski Kenneth Director 2025-06-09 Purchase 10b5-1 +45 $5.94 $267 285,968 D
Krogulski Kenneth Director 2025-06-10 Purchase 10b5-1 +45 $6.00 $270 286,013 D
Krogulski Kenneth Director 2025-06-11 Purchase 10b5-1 +45 $5.57 $251 286,058 D
Krogulski Kenneth Director 2025-06-12 Purchase 10b5-1 +45 $5.67 $255 286,103 D
Krogulski Kenneth Director 2025-06-13 Purchase 10b5-1 +45 $5.81 $261 286,148 D
Krogulski Kenneth Director 2025-06-16 Purchase 10b5-1 +45 $5.32 $239 286,193 D
Krogulski Kenneth Director 2025-06-17 Purchase 10b5-1 +45 $5.61 $252 286,238 D
Krogulski Kenneth Director 2025-06-18 Purchase 10b5-1 +45 $5.52 $248 286,283 D
Krogulski Kenneth Director 2025-06-20 Purchase 10b5-1 +45 $5.29 $238 286,328 D
Krogulski Kenneth Director 2025-06-23 Purchase 10b5-1 +45 $4.61 $207 286,373 D
Krogulski Kenneth Director 2025-06-24 Purchase 10b5-1 +45 $3.91 $176 286,418 D
Krogulski Kenneth Director 2025-06-25 Purchase 10b5-1 +45 $3.27 $147 286,463 D
Krogulski Kenneth Director 2025-06-26 Purchase 10b5-1 +45 $2.71 $122 286,508 D
Krogulski Kenneth Director 2025-06-27 Purchase 10b5-1 +45 $2.60 $117 286,553 D
Krogulski Kenneth Director 2025-06-30 Purchase 10b5-1 +80 $2.74 $219 286,633 D
Open-market purchases · 935 sh · avg $4.83 · $4,513
Loading xslF345X05/wk-form4_1752270372.xml…